Protagonist Therapeutics
WKN: A2AP32 / ISIN: US74366E1029Protagonist Therapeutics: Buy rating nach Absturz
| eröffnet am: | 20.09.21 13:22 von: | moneywork4me |
| neuester Beitrag: | 22.09.21 16:43 von: | Balu4u |
| Anzahl Beiträge: | 6 | |
| Leser gesamt: | 1561 | |
| davon Heute: | 1 | |
bewertet mit 0 Sternen |
||
|
|
||
20.09.21 13:22
#1
moneywork4me
Protagonist Therapeutics: Buy rating nach Absturz
https://www.analystratings.com/articles/...agonist-therapeutics-ptgx/
Hintergrund des Absturzes:
https://investorplace.com/2021/09/...nvestorPlace+%28InvestorPlace%29
https://www.protagonist-inc.com/pipeline/
Hintergrund des Absturzes:
https://investorplace.com/2021/09/...nvestorPlace+%28InvestorPlace%29
https://www.protagonist-inc.com/pipeline/
20.09.21 20:06
#3
Balu4u
doesn't allow a company to run any trials
Daher fällt es wohl weiter stark:
Investors should probably assume the entire rusfertide program is toast. Convincing the FDA an early clinical-stage drug doesn't cause cancer is nearly impossible when the agency doesn't allow a company to run any trials.
https://www.fool.com/investing/2021/09/17/...s-stock-is-tanking-toda/
Investors should probably assume the entire rusfertide program is toast. Convincing the FDA an early clinical-stage drug doesn't cause cancer is nearly impossible when the agency doesn't allow a company to run any trials.
https://www.fool.com/investing/2021/09/17/...s-stock-is-tanking-toda/
21.09.21 17:25
#5
moneywork4me
Kampf mit der 15 gewonnen?
https://www.nasdaq.com/de/market-activity/stocks/ptgx/real-time
22.09.21 16:43
#6
Balu4u
Will This Strength Last?
https://www.finanzen.net/nachricht/aktien/...s-strength-last-10556185